Which closed-end funds own Teva Pharmaceuticals Ne?
11 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $13.2M. Security type: debt security. Country: Netherlands. CUSIP 88167AAE1 · ISIN US88167AAE10.
Holdings are historical filings (report dates May 29, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| EMD Western Asset Emerging Markets Debt Fund | Taxable Bonds | 0.76% | $6.5M | 6,500,000 par | $852M | 11.3% discount | Jun 30, 2026 |
| HIX Western Asset High Income Fund II | High Yield | 0.49% | $2.5M | 2,500,000 par | $513M | NAV unavailable | Jul 31, 2026 |
| EHI Western Asset Global High Income Fund | High Yield | 0.25% | $697K | 700,000 par | $277M | 11.4% discount | May 29, 2026 |
| GDO Western Asset Global Corporate Opportunity Fund | Multi-Asset | 0.20% | $239K | 240,000 par | $121M | 6.9% discount | Jul 31, 2026 |
| BIT BlackRock Multi-Sector Income Trust | Multi-Asset | 0.11% | $820K | 823,000 par | $747M | 10.3% discount | Jun 30, 2026 |
| BHK BlackRock Core Bond Trust | Investment Grade | 0.11% | $744K | 747,000 par | $688M | 6.1% discount | Jun 30, 2026 |
| BTZ BlackRock Credit Allocation Income Trust | Taxable Bonds | 0.06% | $676K | 679,000 par | $1.2B | 9.0% discount | Jun 30, 2026 |
| HYT BlackRock Corporate High Yield Fund | High Yield | 0.03% | $671K | 674,000 par | $2.5B | 10.7% discount | Jun 30, 2026 |
| BLW BlackRock Ltd Duration Income Trust | Taxable Bonds | 0.02% | $95.6K | 96,000 par | $532M | 7.8% discount | Jun 30, 2026 |
| DSU BlackRock Debt Strategies Fund | Taxable Bonds | 0.02% | $129K | 130,000 par | $750M | 6.6% discount | Jun 30, 2026 |
| ECAT BlackRock ESG Capital Allocation Term Trust | U.S. Equity | 0.01% | $118K | 118,000 par | $1.7B | NAV unavailable | Jun 30, 2026 |
11 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV.
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Teva Pharmaceuticals Ne | debt security | 4 |
| Teva Pharmaceuticals Ne | debt security | 2 |
| Teva Pharmaceuticals Ne | debt security | 2 |
| Teva Pharmaceuticals Ne | debt security | 1 |
| Teva Pharmaceuticals Ne | debt security | 1 |
| Teva Pharmaceuticals Ne | debt security | 1 |
Issuer-level search for “TEVA PHARMACEUTICALS NE” → · Compare two funds’ portfolios →